The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global Bacteriophage market was valued at US$ 37 million in 2023 and is anticipated to reach US$ 121.4 million by 2030, witnessing a CAGR of 18.8% during the forecast period 2024-2030.
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
Report Scope
The Bacteriophage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences, Inc
- Pharmex Group, LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
Segment by Type
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
Segment by Application
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bacteriophage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bacteriophage Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Market Perspective (2019-2030)
2.2 Bacteriophage Growth Trends by Region
2.2.1 Global Bacteriophage Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bacteriophage Historic Market Size by Region (2019-2024)
2.2.3 Bacteriophage Forecasted Market Size by Region (2025-2030)
2.3 Bacteriophage Market Dynamics
2.3.1 Bacteriophage Industry Trends
2.3.2 Bacteriophage Market Drivers
2.3.3 Bacteriophage Market Challenges
2.3.4 Bacteriophage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Players by Revenue
3.1.1 Global Top Bacteriophage Players by Revenue (2019-2024)
3.1.2 Global Bacteriophage Revenue Market Share by Players (2019-2024)
3.2 Global Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bacteriophage Revenue
3.4 Global Bacteriophage Market Concentration Ratio
3.4.1 Global Bacteriophage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Revenue in 2023
3.5 Bacteriophage Key Players Head office and Area Served
3.6 Key Players Bacteriophage Product Solution and Service
3.7 Date of Enter into Bacteriophage Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bacteriophage Breakdown Data by Type
4.1 Global Bacteriophage Historic Market Size by Type (2019-2024)
4.2 Global Bacteriophage Forecasted Market Size by Type (2025-2030)
5 Bacteriophage Breakdown Data by Application
5.1 Global Bacteriophage Historic Market Size by Application (2019-2024)
5.2 Global Bacteriophage Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bacteriophage Market Size (2019-2030)
6.2 North America Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bacteriophage Market Size by Country (2019-2024)
6.4 North America Bacteriophage Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bacteriophage Market Size (2019-2030)
7.2 Europe Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bacteriophage Market Size by Country (2019-2024)
7.4 Europe Bacteriophage Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Market Size (2019-2030)
8.2 Asia-Pacific Bacteriophage Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bacteriophage Market Size by Region (2019-2024)
8.4 Asia-Pacific Bacteriophage Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bacteriophage Market Size (2019-2030)
9.2 Latin America Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bacteriophage Market Size by Country (2019-2024)
9.4 Latin America Bacteriophage Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Market Size (2019-2030)
10.2 Middle East & Africa Bacteriophage Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bacteriophage Market Size by Country (2019-2024)
10.4 Middle East & Africa Bacteriophage Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Detail
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Bacteriophage Introduction
11.1.4 NPO Microgen Revenue in Bacteriophage Business (2019-2024)
11.1.5 NPO Microgen Recent Development
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Detail
11.2.2 Proteon Pharmaceuticals Business Overview
11.2.3 Proteon Pharmaceuticals Bacteriophage Introduction
11.2.4 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2019-2024)
11.2.5 Proteon Pharmaceuticals Recent Development
11.3 Phagelux
11.3.1 Phagelux Company Detail
11.3.2 Phagelux Business Overview
11.3.3 Phagelux Bacteriophage Introduction
11.3.4 Phagelux Revenue in Bacteriophage Business (2019-2024)
11.3.5 Phagelux Recent Development
11.4 Intralytix
11.4.1 Intralytix Company Detail
11.4.2 Intralytix Business Overview
11.4.3 Intralytix Bacteriophage Introduction
11.4.4 Intralytix Revenue in Bacteriophage Business (2019-2024)
11.4.5 Intralytix Recent Development
11.5 Micreos
11.5.1 Micreos Company Detail
11.5.2 Micreos Business Overview
11.5.3 Micreos Bacteriophage Introduction
11.5.4 Micreos Revenue in Bacteriophage Business (2019-2024)
11.5.5 Micreos Recent Development
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Detail
11.6.2 Eliava BioPreparations Business Overview
11.6.3 Eliava BioPreparations Bacteriophage Introduction
11.6.4 Eliava BioPreparations Revenue in Bacteriophage Business (2019-2024)
11.6.5 Eliava BioPreparations Recent Development
11.7 Locus Biosciences, Inc
11.7.1 Locus Biosciences, Inc Company Detail
11.7.2 Locus Biosciences, Inc Business Overview
11.7.3 Locus Biosciences, Inc Bacteriophage Introduction
11.7.4 Locus Biosciences, Inc Revenue in Bacteriophage Business (2019-2024)
11.7.5 Locus Biosciences, Inc Recent Development
11.8 Pharmex Group, LLC
11.8.1 Pharmex Group, LLC Company Detail
11.8.2 Pharmex Group, LLC Business Overview
11.8.3 Pharmex Group, LLC Bacteriophage Introduction
11.8.4 Pharmex Group, LLC Revenue in Bacteriophage Business (2019-2024)
11.8.5 Pharmex Group, LLC Recent Development
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Detail
11.9.2 Pherecydes Pharma Business Overview
11.9.3 Pherecydes Pharma Bacteriophage Introduction
11.9.4 Pherecydes Pharma Revenue in Bacteriophage Business (2019-2024)
11.9.5 Pherecydes Pharma Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Detail
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2019-2024)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Detail
11.11.2 Qingdao Phagepharm Bio-tech Business Overview
11.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Introduction
11.11.4 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2019-2024)
11.11.5 Qingdao Phagepharm Bio-tech Recent Development
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Detail
11.12.2 Fixed-Phage Limited Business Overview
11.12.3 Fixed-Phage Limited Bacteriophage Introduction
11.12.4 Fixed-Phage Limited Revenue in Bacteriophage Business (2019-2024)
11.12.5 Fixed-Phage Limited Recent Development
11.13 Zeptometrix
11.13.1 Zeptometrix Company Detail
11.13.2 Zeptometrix Business Overview
11.13.3 Zeptometrix Bacteriophage Introduction
11.13.4 Zeptometrix Revenue in Bacteriophage Business (2019-2024)
11.13.5 Zeptometrix Recent Development
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Detail
11.14.2 Phage International, Inc. Business Overview
11.14.3 Phage International, Inc. Bacteriophage Introduction
11.14.4 Phage International, Inc. Revenue in Bacteriophage Business (2019-2024)
11.14.5 Phage International, Inc. Recent Development
11.15 MicroMir
11.15.1 MicroMir Company Detail
11.15.2 MicroMir Business Overview
11.15.3 MicroMir Bacteriophage Introduction
11.15.4 MicroMir Revenue in Bacteriophage Business (2019-2024)
11.15.5 MicroMir Recent Development
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Detail
11.16.2 iNtODEWORLD, Inc. Business Overview
11.16.3 iNtODEWORLD, Inc. Bacteriophage Introduction
11.16.4 iNtODEWORLD, Inc. Revenue in Bacteriophage Business (2019-2024)
11.16.5 iNtODEWORLD, Inc. Recent Development
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Detail
11.17.2 NEXTBIOTICS Business Overview
11.17.3 NEXTBIOTICS Bacteriophage Introduction
11.17.4 NEXTBIOTICS Revenue in Bacteriophage Business (2019-2024)
11.17.5 NEXTBIOTICS Recent Development
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Detail
11.18.2 Armata Pharmaceuticals, Inc. Business Overview
11.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Introduction
11.18.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2019-2024)
11.18.5 Armata Pharmaceuticals, Inc. Recent Development
11.19 Innophage
11.19.1 Innophage Company Detail
11.19.2 Innophage Business Overview
11.19.3 Innophage Bacteriophage Introduction
11.19.4 Innophage Revenue in Bacteriophage Business (2019-2024)
11.19.5 Innophage Recent Development
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Detail
11.20.2 Adaptive Phage Therapeutics Business Overview
11.20.3 Adaptive Phage Therapeutics Bacteriophage Introduction
11.20.4 Adaptive Phage Therapeutics Revenue in Bacteriophage Business (2019-2024)
11.20.5 Adaptive Phage Therapeutics Recent Development
11.21 TechnoPhage
11.21.1 TechnoPhage Company Detail
11.21.2 TechnoPhage Business Overview
11.21.3 TechnoPhage Bacteriophage Introduction
11.21.4 TechnoPhage Revenue in Bacteriophage Business (2019-2024)
11.21.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
